CLDN18 and cancer: Moreover, Kaplan–Meier analysis of these cancers individually revealed that high CLDN18.2 expression was a poor prognostic factor in BLCA (P = 0.013), ESCA (P = 0.021) and PAAD (P = 0.002) (Figure 5C).